- The global veterinary medicine market is forecast to grow from $49.96 billion in 2026 to $95.63 billion by 2035.
- The market is expected to expand at a 7.48% compound annual growth rate.
- Rising pet ownership and pet humanization remain major growth drivers.
- Vaccines and biologic therapies are expected to outpace traditional pharmaceutical segments.
- Asia-Pacific is projected to be the fastest-growing regional market through 2035.
The global veterinary medicine market could approach $100 billion within the next decade, according to a new report from Market Research Future, reflecting continued investment and innovation across companion animal and livestock health sectors.
The report forecasts market growth from $49.96 billion in 2026 to $95.63 billion by 2035, representing a compound annual growth rate of 7.48%.
Researchers attribute much of that growth to rising pet ownership, increasing spending on companion animal healthcare, expanding use of vaccines and biologic therapies, and growing adoption of advanced diagnostics and precision medicine technologies.
Companion Animal Care Continues to Lead
Companion animals remain the largest segment of the veterinary medicine market, accounting for more than half of industry revenue. The report cites continued pet humanization trends and increasing willingness among owners to pursue advanced treatments for chronic conditions, including osteoarthritis, oncology, cardiology and endocrine disorders.
The growing success of biologic therapies such as Librela and Solensia have demonstrated strong demand for targeted therapies that address chronic disease while improving quality of life for pets.
Vaccines and Biologics Gain Momentum
While traditional pharmaceuticals continue to represent the largest revenue category, vaccines are expected to be among the fastest-growing segments through 2035.
Regulatory efforts aimed at reducing antimicrobial use in livestock production are accelerating the adoption of preventive health strategies, including vaccines, probiotics and other alternatives to antibiotics.
Asia-Pacific Emerges as Growth Engine
North America remains the largest regional market, supported by high pet ownership rates, advanced veterinary infrastructure and growing adoption of premium therapies.
However, Asia-Pacific is expected to deliver the fastest growth over the forecast period. Expanding middle-class populations, increasing pet ownership and investments in livestock production are driving demand across major markets including China, India and South Korea.
Industry Investment Signals Confidence
The market outlook arrives as animal health companies continue to invest heavily in future growth opportunities. Recent announcements such as Elanco’s $25 million commitment to launch Elanco Ventures highlight broader industry confidence in emerging technologies, therapeutics and digital health platforms.
The report also points to growing investment in artificial intelligence, diagnostic technologies and precision medicine tools that could further transform veterinary practice over the next decade.
For readers seeking a deeper analysis of market forecasts, regional trends, competitive dynamics and company-specific developments, the full report is available from Market Research Future: https://www.marketresearchfuture.com/reports/veterinary-medicine-market-844
Information sourced from a Market Research Future industry report.
